港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物醫藥B類股

483.155

0.000

漲家數：10

跌家數：1

平家數：22

市盈率：- -

高：483.155

開：483.155

低：483.155

收：483.155

成交量：- -

成交額：- -

市值：3,113.56億

流通市值：2,776.56億

資料載入中...

歌禮制藥-B：董事會建議不派發中期股息

康寧傑瑞製藥-B(09966.HK)8月31日斥資97.91萬港元回購11萬股

先瑞達醫療-B(06669.HK)公布中期業績淨虧損8083.3萬元按年盈轉虧

歸創通橋(02190.HK)8月31日斥資112.77萬港元回購5.3萬股

李安康減持騰盛博藥-B(02137.HK)1500股每股作價0.955港元

透景生命(300642.SZ)子公司取得醫療器械註冊證

歐康維視生物-B(01477)：OT-202 III期臨床試驗完成首例患者入組

明星創新藥企走到十字路口：四衝港股，半年虧16 億元，百利天恒要跨過的三道坎

李氏大藥廠(00950)公布中期業績擁有人應占溢利9501.4萬港元按年增長41.4%

ST百靈(002424.SZ)子公司創新藥吸入用BD77臨床試驗申請獲批

心瑋醫療-B(06609.HK)發布中期業績股東應占利潤6036.5萬元按年增長18.5%

凱普生物(300639.SZ)子公司取得醫療器械註冊證書

港股異動 | 開拓藥業-B(09939)升逾5% 上半年虧損按年收窄化妝品銷售帶動收入激增

中國貿促會：6月份全球經貿摩擦指數處於高位衝突點聚焦電子、化工、醫藥等行業

今天北交所新股百邁科申購，聚焦外科手術醫療器械領域

BioNTech暫停mRNA臨床試驗，康希諾領跌香港上市疫苗股

康方生物(09926)出現大手賣出22.3萬股，成交價$90.0，涉資2.007千萬

阿斯达克财经

《業績》北海康成製藥(01228.HK)中期盈轉虧蝕3709萬人民幣

阿斯达克财经

大行評級丨高盛：上調諾誠健華目標價至22.71港元，未來12至18個月催化劑眾多

迪哲醫藥、劇星傳媒遞表港交所；星環科技通過港交所聆訊｜港交所早參

每日经济新闻

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BK1574/news?page=17"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":483.15506,"timestamp":1789349123072,"preClose":483.15506,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"開市前","change":0,"latestTime":"09-14 09:25:23","open":483.15506,"high":483.15506,"low":483.15506,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789349400000,1789358400000],[1789362000000,1789372800000]],"pbRate":3.606253,"peRate":160.422718,"turnoverRate":0.004389,"increases":10,"decrements":1,"flats":21,"marketCap":311355886608,"floatMarketCap":277656397992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":483.15506,"amplitude":0,"preClose":483.15506,"low":483.15506,"pbRate":"3.606253","latestPrice":483.15506,"volume":0,"delay":0,"open":483.15506,"prevYearClose":556.26263,"prevWeekClose":483.155,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":516.325,"twentyDayClose":505.128,"sixtyDayClose":444.911,"secType":"PLATE","market":"HK","turnoverRate":0.004389,"peRate":160.422718,"marketCap":311355886608,"floatMarketCap":277656397992,"timestamp":1789349123099,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":10,"down":1,"flat":22},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:17,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1162031632","title":"歌禮制藥-B：董事會建議不派發中期股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1162031632","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162031632?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 21:18","pubTimestamp":1788182334,"startTime":"0","endTime":"0","summary":"歌礼制药-B（01672.HK）宣布，其董事会已决定不建议就中期业绩派发任何股息。这一决定反映出公司在当前阶段的财务策略与资本配置考量。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK1515","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663003791","title":"康寧傑瑞製藥-B(09966.HK)8月31日斥資97.91萬港元回購11萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663003791","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663003791?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 20:47","pubTimestamp":1788180441,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","09966","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663610070","title":"先瑞達醫療-B(06669.HK)公布中期業績 淨虧損8083.3萬元 按年盈轉虧","url":"https://stock-news.laohu8.com/highlight/detail?id=2663610070","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663610070?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 19:30","pubTimestamp":1788175816,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK1100","BK1587","06669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663077473","title":"歸創通橋(02190.HK)8月31日斥資112.77萬港元回購5.3萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663077473","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663077473?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 19:14","pubTimestamp":1788174892,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK1587","BK1100","02190","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663077159","title":"李安康減持騰盛博藥-B(02137.HK)1500股 每股作價0.955港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663077159","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663077159?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 19:10","pubTimestamp":1788174625,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK1161","BK1587","02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663074020","title":"透景生命(300642.SZ)子公司取得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2663074020","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663074020?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:34","pubTimestamp":1788172480,"startTime":"0","endTime":"0","summary":"智通财经APP讯，透景生命(300642.SZ)发布公告，公司控股子公司河北透景生命科技有限公司于近日取得国家药品监督管理局颁发的1项医疗器械注册证，产品为曲霉半乳甘露聚糖检测试剂盒(磁微粒化学发光法)。该产品可用于体外定性检测人血清或肺泡灌洗液样本中的曲霉半乳甘露聚糖，其检测结果用于曲霉感染的辅助诊断。此次医疗器械注册证的取得，将进一步增强公司及子公司在真菌检测领域的综合竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489611.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGNG","LGHT","MDEV","MEDX","GDOC","BK0239","RSPH","BK1100","300642","BK0046","IEIH","BK1583","BK0042","09996","PTH","HART","159883","BK1574","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663074148","title":"歐康維視生物-B(01477)：OT-202 III期臨床試驗完成首例患者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2663074148","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663074148?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:26","pubTimestamp":1788171975,"startTime":"0","endTime":"0","summary":"智通财经APP讯，欧康维视生物-B 发布公告，用于治疗干眼症的 OT-202于中国进行的III期临床试验已完成首例患者入组。首例患者成功入组标志着OT-202在中国临床开发的一项重要里程碑，并体现集团为干眼症患者推进创新疗法的承诺。OT-202的II期临床试验，已于2023年11月于中国完成合共213名患者的II期临床试验入组。OT-202的II期临床试验结果已在国际顶尖眼科期刊《Ophthalmology》发表。2024年3月，OT-202的II期临床试验达到其主要终点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489598.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IBBJ","BK1191","01477","MDTX","PSYK","BMED","IBBQ","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663957074","title":"明星創新藥企走到十字路口：四衝港股，半年虧16 億元，百利天恒要跨過的三道坎","url":"https://stock-news.laohu8.com/highlight/detail?id=2663957074","media":"华夏时报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663957074?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:12","pubTimestamp":1788171125,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/L5M98DIN0512D03F.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/L5M98DIN0512D03F.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["06978","91194","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071315","title":"李氏大藥廠(00950)公布中期業績 擁有人應占溢利9501.4萬港元 按年增長41.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071315","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071315?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 17:50","pubTimestamp":1788169857,"startTime":"0","endTime":"0","summary":"智通财经APP讯，李氏大药厂 公布2026年中期业绩，收益约7.97亿港元，同比增长14.6%;公司拥有人应占溢利9501.4万港元，同比增长41.4%;每股盈利16.14港仙，每股中期股息3.5港仙。其中，引进产品的收益增加24.3%至约3.37亿港元，主要源于《菲普利》、《布累迪宁》、《曲特恪》及《芮舒延》的贡献。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489545.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","06622","BK1191","BK1583","00950","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079555","title":"ST百靈(002424.SZ)子公司創新藥吸入用BD77臨床試驗申請獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079555","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663079555?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 17:29","pubTimestamp":1788168556,"startTime":"0","endTime":"0","summary":"智通财经APP讯，ST百灵 发布公告，近日，公司全资子公司百灵毓秀(珠海)医药有限公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，公司创新药吸入用BD77临床试验申请获得批准，同意开展用于慢性阻塞性肺病的临床试验。据悉，吸入用BD77是来源于单一法定中药材经分离纯化获得的纯度超过98%的小分子化学药。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489501.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IBBJ","002424","BMED","BK0146","BK1574","159992","PSYK","BK0188","MEDX","BK1161","LNGR","IBBQ","BK0183","BK0028","MDTX","06978","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076966","title":"心瑋醫療-B(06609.HK)發布中期業績 股東應占利潤6036.5萬元 按年增長18.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076966","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076966?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 17:08","pubTimestamp":1788167331,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06609","BK1100","BK1587","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663075807","title":"凱普生物(300639.SZ)子公司取得醫療器械註冊證書","url":"https://stock-news.laohu8.com/highlight/detail?id=2663075807","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663075807?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 16:36","pubTimestamp":1788165374,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯普生物(300639.SZ)发布公告，近日，公司的全资子公司潮州凯普生物化学有限公司(简称“凯普化学”)取得国家药品监督管理局颁发的《中华人民共和国医疗器械注册证(体外诊断试剂)》，产品名称：基孔肯雅病毒/登革病毒核酸检测试剂盒(荧光PCR法)，该产品用于体外定性检测人血清或血浆样本中的基孔肯雅病毒和登革病毒的核酸。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489401.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","IEIH","LGHT","AGNG","BK0042","BK1583","BK1574","RSPH","BK0046","LNGR","BK0132","PTH","300639","BK1100","MDEV","GDOC","09996","HART","159883","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663078277","title":"港股異動 | 開拓藥業-B(09939)升逾5% 上半年虧損按年收窄 化妝品銷售帶動收入激增","url":"https://stock-news.laohu8.com/highlight/detail?id=2663078277","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663078277?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 15:44","pubTimestamp":1788162244,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，开拓药业-B(09939)涨超5%，截至发稿，涨5.56%，报1.71港元，成交额365.81万港元。消息面上，开拓药业2026年中期业绩显示，收益由去年同期600万元增至截至2026年6月30日止六个月的5200万元，净亏损7578.2万元，同比减少8.99%。公告称，收益增加主要由于直播电商销售带动新高端化妆品品牌KOSHINÉ(其主要成分KX-826为公司的核心产品之一)的全球销售。净亏损减少主要由于研发成本减少，部分被主要因营销及推广开支增加导致销售及营销开支增加所抵销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1574","BK4588","09939","BK4585","VXUS","KCAI","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663665078","title":"中國貿促會：6月份全球經貿摩擦指數處於高位 衝突點聚焦電子、化工、醫藥等行業","url":"https://stock-news.laohu8.com/highlight/detail?id=2663665078","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663665078?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 15:19","pubTimestamp":1788160740,"startTime":"0","endTime":"0","summary":"8月31日，中国贸促会举行8月例行新闻发布会，新闻发言人就全球经贸摩擦指数、促进上合组织工商界交流与合作等热点话题进行了回应。中国贸促会新闻发言人杨帆表示，从综合指数看，2026年6月 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260831/c679442975.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260831/c679442975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK1574","BK1515","09939","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663208770","title":"今天北交所新股百邁科申購，聚焦外科手術醫療器械領域","url":"https://stock-news.laohu8.com/highlight/detail?id=2663208770","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663208770?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 14:57","pubTimestamp":1788159461,"startTime":"0","endTime":"0","summary":"顶格申购所需资金约811万元","market":"us","thumbnail":"https://img3.gelonghui.com/6cf81-9c6111b2-4705-4ed4-93b5-2372ef807bf8.jpg?guru_height=852&guru_width=1280&guru_size=179202","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/6cf81-9c6111b2-4705-4ed4-93b5-2372ef807bf8.jpg?guru_height=852&guru_width=1280&guru_size=179202"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6430275","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1574","MEDX","RSPH","GDOC","PTH","LNGR","BK1583","BK1100","09996","159883","HART","LGHT","AGNG","MDEV","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663440024","title":"BioNTech暫停mRNA臨床試驗，康希諾領跌香港上市疫苗股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663440024","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663440024?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 13:11","pubTimestamp":1788153070,"startTime":"0","endTime":"0","summary":"BUZZ-BioNTech暂停mRNA临床试验，康希诺领跌香港上市疫苗股8月31日-** 康希诺生物6185.HK领跌香港上市的中国疫苗股，此前有消息称 BioNTech22UAy.DE因安全审查而暂停了 (link) mRNA 结直肠癌疫苗的临床试验** 康希诺香港股价下跌8.6%至29.02港元，上海股价688185.SS下跌9.4%至75.08元** BioNTech表示，在独立委员会认定该","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4T44S0DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BNTX","BK4535","BK1191","BK4585","BK1515","688185","BK1574","BK4551","BK4568","BK4548","BK4588","06185","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663715024","title":"康方生物(09926)出現大手賣出22.3萬股，成交價$90.0，涉資2.007千萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2663715024","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663715024?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 13:00","pubTimestamp":1788152400,"startTime":"0","endTime":"0","summary":"[大手成交]康方生物(09926)在下午01:00出现大手卖出，成交量为22.3万，成交价为港币$90.0，涉资2.007千万。至目前为止，股价跌5.558%，今日最高价为$93.7，而最低价为$90.0，总成交量为806.679万股，总成交金额港币$7.369亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2608314786/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2608314786/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0348825331.USD","IE00BPRC5H50.USD","LU0348735423.USD","LU0561508036.HKD","LU1720050803.USD","LU2476274720.SGD","LU2399975544.HKD","LU0348767384.USD","LU2778985437.USD","LU0348766576.USD","BK1161","KURE","LU0417516571.SGD","LU0417516902.SGD","IE00B5MMRT66.SGD","LU1961090484.USD","LU0540923850.HKD","LU2488822045.USD","LU0417516738.SGD","09926","LU2476274308.USD","LU0634319403.HKD","LU0348827113.USD","IE00B543WZ88.USD","LU1794554557.SGD","BK1574","LU0348783233.USD","LU0348784397.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663024324","title":"《業績》北海康成製藥(01228.HK)中期盈轉虧蝕3709萬人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2663024324","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663024324?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 12:32","pubTimestamp":1788150720,"startTime":"0","endTime":"0","summary":"北海康成制药(01228.HK) 公布2026年6月底止六个月中期业绩，收入2,794万人民币(下同)，按年升25.6%。盈转亏蚀3,709万，上年同期纯利5,924万；每股亏损7分。不派息。(ad/)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2026/03/30末期业绩无派息2025/08/31中期业绩无派息2025/03/31末期业绩无派息2024/08/30中期业绩无派息AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220106153104382_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220106153104382_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542088/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542088/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","MCNHmain","01477","MUCmain","CYB","UCmain","BK1161","CNHmain","BK1574","01228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663502955","title":"大行評級丨高盛：上調諾誠健華目標價至22.71港元，未來12至18個月催化劑眾多","url":"https://stock-news.laohu8.com/highlight/detail?id=2663502955","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663502955?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 10:47","pubTimestamp":1788144425,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["09969","BK1574","688428","BK1161","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663902673","title":"迪哲醫藥、劇星傳媒遞表港交所；星環科技通過港交所聆訊｜港交所早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2663902673","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663902673?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 10:26","pubTimestamp":1788143206,"startTime":"0","endTime":"0","summary":"｜2026年8月31日星期一｜NO.1迪哲医药、剧星传媒递表港交所据港交所8月27日披露，迪哲（江苏）医药股份有限公司（以下简称迪哲医药，SH688192）、上海剧星传媒股份有限公司（以下简称剧星传媒）已向港交所主板递交上市申请。迪哲医药是一家处于商业化阶段的生物制药公司，公司的核心治疗领域是肿瘤及血液系统疾病。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313859847470.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313859847470.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1128","BK1574","159938","BK1515","IPOS","91222","01981","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":17,"totalSize":342,"code":"91000000","status":"200"}]}}